全球动脉插管市场规模、份额、趋势和成长分析报告（2026-2034年）

预计动脉插管市场将从 2025 年的 2,970 万美元成长到 2034 年的 5,786 万美元，2026 年至 2034 年的复合年增长率为 7.69%。

受全球心血管手术和重症监护手术数量不断增加的推动，全球动脉插管市场正经历稳定成长。动脉插管是心肺体外迴圈和体外循环手术中不可或缺的医疗设备。心臟病发病率的上升和手术复杂性的增加，显着促进了产品需求的成长。

关键成长要素包括微创手术技术的进步和医疗基础设施的改善。旨在提高患者安全性和减少併发症的技术创新正在推动市场扩张。尤其值得注意的是，已开发国家人口老化加剧了对心血管手术的需求。此外，新兴国家医疗服务覆盖范围的扩大也为製造商创造了新的机会。

展望未来，由于心臟护理技术的进步和医疗保健投资的增加，市场预计将稳定成长。生物相容性材料的开发和设计能力的提升将进一步增强产品性能。人们对早期心臟介入重要性的认识不断提高，也将推动市场需求。鑑于心血管疾病仍然是全球主要的健康问题，动脉插管市场是一个具有长期成长潜力的领域。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球动脉插管市场：依尺寸划分

• 市场分析、洞察与预测
• 14-16 Fr
• 17-19 Fr
• 20-22 Fr
• 23-25 Fr
• 26-28 Fr
• 29-31 Fr
• 32-34 Fr
• 35-36 Fr

第五章 全球动脉插管市场：依应用领域划分

• 市场分析、洞察与预测
• 心肺体外迴圈手术
• 体外膜氧合器
• 其他用途

第六章：全球动脉插管市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 门诊手术中心
• 其他最终用户

第七章 全球动脉插管市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Andocor
  • B. Braun
  • Becton Dickinson And Company
  • Edwards Lifesciences
  • Freelife Medical
  • Fresenius Medical Care
  • Getinge
  • ICU Medical
  • Kangxin Medical
  • LivaNova
  • Medtronic
  • Nipro Corporation
  • Polymedicure
  • Surgical Holdings
  • Terumo Corporation

The Arterial Cannula Market size is expected to reach USD 57.86 Million in 2034 from USD 29.70 Million (2025) growing at a CAGR of 7.69% during 2026-2034.

The Global Arterial Cannula Market is experiencing steady growth, driven by increasing cardiovascular surgeries and critical care procedures worldwide. Arterial cannulas are essential medical devices used in cardiopulmonary bypass and extracorporeal circulation procedures. The rising prevalence of heart diseases and the growing number of complex surgical interventions have significantly contributed to increased product demand.

Major growth drivers include advancements in minimally invasive surgical techniques and improvements in healthcare infrastructure. Technological innovations aimed at enhancing patient safety and reducing complications are strengthening market expansion. The aging population, particularly in developed countries, is also increasing the need for cardiac procedures. Furthermore, expanding access to healthcare services in emerging economies is creating new opportunities for manufacturers.

Looking forward, the market is expected to grow steadily with the advancement of cardiac care technologies and rising healthcare investments. Development of biocompatible materials and improved design features will enhance product performance. Increasing awareness about early cardiac intervention will further support demand. As cardiovascular disease remains a leading global health concern, the Arterial Cannula Market is positioned for long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Size

• 14-16 Fr
• 17-19 Fr
• 20-22 Fr
• 23-25 Fr
• 26-28 Fr
• 29-31 Fr
• 32-34 Fr
• 35-36 Fr

By Application

• Cardiopulmonary Bypass Surgery
• Extracorporeal Membrane Oxygenation
• Other Applications

By End Use

• Hospitals
• Ambulatory Surgical Centers
• Other End Users

COMPANIES PROFILED

• Andocor, B Braun, Becton Dickinson and Company, Edwards Lifesciences, Freelife Medical, Fresenius Medical Care, Getinge, ICU Medical, Kangxin Medical, LivaNova, Medtronic, Nipro Corporation, Polymedicure, Surgical Holdings, Terumo Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ARTERIAL CANNULA MARKET: BY SIZE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Size
• 4.2. 14-16 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. 17-19 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. 20-22 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. 23-25 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. 26-28 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. 29-31 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. 32-34 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. 35-36 Fr Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ARTERIAL CANNULA MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Cardiopulmonary Bypass Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Extracorporeal Membrane Oxygenation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ARTERIAL CANNULA MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ARTERIAL CANNULA MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Size
  • 7.2.2 By Application
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Size
  • 7.3.2 By Application
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Size
  • 7.4.2 By Application
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Size
  • 7.5.2 By Application
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Size
  • 7.6.2 By Application
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ARTERIAL CANNULA INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Andocor
  • 9.2.2 B. Braun
  • 9.2.3 Becton Dickinson And Company
  • 9.2.4 Edwards Lifesciences
  • 9.2.5 Freelife Medical
  • 9.2.6 Fresenius Medical Care
  • 9.2.7 Getinge
  • 9.2.8 ICU Medical
  • 9.2.9 Kangxin Medical
  • 9.2.10 LivaNova
  • 9.2.11 Medtronic
  • 9.2.12 Nipro Corporation
  • 9.2.13 Polymedicure
  • 9.2.14 Surgical Holdings
  • 9.2.15 Terumo Corporation